Maryland Stem Cell Research Commission Announces Over $7 Million in Awards to Accelerate Cures Maryland Stem Cell Research Fund May 16, 2022
ISCT 2022 Interview with Tim Kelly: RoosterBio & ShiftBio Partner to Harness the Power of MSCs & Exosomes The Science Advisory Board May 10, 2022
Portfolio Company RoosterBio Highlighted in Dynamk’s Recent Annual General Meeting Dynamk Capital November 1, 2021
Accelerating the Development of a Novel Cell Therapy for COVID-19–Associated Lung Fibrosis Pharma’s Almanac September 29, 2021
RoosterBio & MBL Beijing Biotech Partner to Accelerate Advanced Therapy Manufacturing in China August 30, 2022
RoosterBio & AGC Biologics Announce Collaboration to Accelerate Manufacturing of Cell & Exosome Therapies August 16, 2022
![$image['alt']](https://www.roosterbio.com/wp-content/uploads/2019/09/img-26.jpg)